Sleep disorders often go unrecognized—and untreated. Jazz Pharmaceuticals wants to change that with a new awareness campaign targeting physicians for rare condition idiopathic hypersomnia.
The "I Have IH" campaign, created in partnership with the Hypersomnia Foundation, began after research found 90% of healthcare providers said they needed more education when it comes to diagnosing idiopathic hypersomnia.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,